Effects of resveratrol supplementation on nitric oxide-mediated vascular outcomes in hypertension: A systematic review
- PMID: 36341766
- DOI: 10.1016/j.niox.2022.10.005
Effects of resveratrol supplementation on nitric oxide-mediated vascular outcomes in hypertension: A systematic review
Abstract
Hypertension is associated with endothelial dysfunction and decreased nitric oxide (NO). It has been proposed that decreasing oxidative stress may help regulate blood pressure by increasing NO concentration. Therefore, the purpose of this systematic review was to determine whether the antioxidant resveratrol effects NO-mediated vascular outcomes in hypertension. A comprehensive literature search of PubMed and EBSCOhost databases was conducted using the terms: "resveratrol" and "nitric oxide or NO" and "hypertension or high blood pressure." Searches were not restricted for year of publication or study design but limited to full-text studies from scholarly, peer-reviewed journals. Ten animal studies published between 2005 and 2017 were identified. Human studies did not meet criteria and were not included. Articles were critically assessed using the Academy of Nutrition and Dietetics' Evidence Analysis Library Quality Criteria Worksheet. All studies evaluated resveratrol supplementation and at least one NO outcome measure including: circulating NO metabolites, endothelial nitric oxide synthase (eNOS) expression, eNOS phosphorylation, and eNOS uncoupling. All but one study assessed blood pressure. Nine of ten studies reported positive significant results of resveratrol supplementation on NO outcomes, and in all but one study, this was seen concomitantly with decreases in blood pressure. Resveratrol supplementation shows promise for improving NO-mediated vascular outcomes and improving blood pressure. Translation to human studies is warranted, with dose of resveratrol considered, as the human equivalency doses are not consistent amongst animal studies. Additionally, a standard battery of tests examining NO-mediated vascular outcomes is needed to ensure generalizability among studies to determine dose-duration effects.
Keywords: Blood pressure; Endothelial dysfunction; Endothelial nitric oxide synthase; Hypertension; Nitric oxide; Resveratrol.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest None.
Similar articles
-
Sertindole for schizophrenia.Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2. Cochrane Database Syst Rev. 2005. PMID: 16034864 Free PMC article.
-
Exercise versus airway clearance techniques for people with cystic fibrosis.Cochrane Database Syst Rev. 2022 Jun 22;6(6):CD013285. doi: 10.1002/14651858.CD013285.pub2. Cochrane Database Syst Rev. 2022. PMID: 35731672 Free PMC article.
-
Inhaled mannitol for cystic fibrosis.Cochrane Database Syst Rev. 2018 Feb 9;2(2):CD008649. doi: 10.1002/14651858.CD008649.pub3. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2020 May 1;5:CD008649. doi: 10.1002/14651858.CD008649.pub4. PMID: 29424930 Free PMC article. Updated.
-
Heliox for croup in children.Cochrane Database Syst Rev. 2021 Aug 16;8(8):CD006822. doi: 10.1002/14651858.CD006822.pub6. Cochrane Database Syst Rev. 2021. PMID: 34397099 Free PMC article.
-
Folate supplementation in people with sickle cell disease.Cochrane Database Syst Rev. 2018 Mar 16;3(3):CD011130. doi: 10.1002/14651858.CD011130.pub3. Cochrane Database Syst Rev. 2018. PMID: 29546732 Free PMC article.
Cited by
-
Effects of Nitric Oxide Supplementation on the Levels of Interleukin-6 in Saliva after Dental Implant Placement - A Prospective Study.Ann Maxillofac Surg. 2023 Jul-Dec;13(2):195-199. doi: 10.4103/ams.ams_77_23. Epub 2023 Oct 30. Ann Maxillofac Surg. 2023. PMID: 38405560 Free PMC article.
-
Vascular function: a key player in hypertension.Hypertens Res. 2023 Sep;46(9):2145-2158. doi: 10.1038/s41440-023-01354-3. Epub 2023 Jun 27. Hypertens Res. 2023. PMID: 37369849 Review.
-
Resveratrol Butyrate Esters Reduce Hypertension in a Juvenile Rat Model of Chronic Kidney Disease Exacerbated by Microplastics.Nutrients. 2024 Nov 27;16(23):4076. doi: 10.3390/nu16234076. Nutrients. 2024. PMID: 39683469 Free PMC article.
-
Phytochemical Composition of Ziziphus lotus (L.) Lam and Its Impact on the Metabolic Syndrome: A Review.Adv Pharmacol Pharm Sci. 2025 Feb 17;2025:8276090. doi: 10.1155/adpp/8276090. eCollection 2025. Adv Pharmacol Pharm Sci. 2025. PMID: 40035065 Free PMC article. Review.
-
Use of Germination to Enhance Resveratrol Content and Its Anti-Inflammatory Activity in Lipopolysaccharide-Stimulated RAW264.7 Cells.Molecules. 2023 Jun 21;28(13):4898. doi: 10.3390/molecules28134898. Molecules. 2023. PMID: 37446559 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical